RAPT Therapeutics, Inc.

CIK 1673772 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for RAPT Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
May 15, 2026SCHEDULE 13G/A0000947871-26-000551
May 15, 2026SCHEDULE 13G/A0001493215-26-000114
Mar 18, 202615-12G0001193125-26-112753
Mar 5, 202640001337831-26-000001
Mar 5, 202640001643875-26-000006
Mar 5, 202640001733915-26-000003
Mar 5, 202640001646110-26-000001
Mar 5, 202640001693564-26-000003
Mar 5, 202640001635616-26-000001
Mar 5, 202640001782274-26-000003
Mar 5, 202640001270774-26-000003
Mar 5, 202640001261974-26-000003
Mar 4, 2026EFFECT9999999995-26-000717
Mar 4, 2026EFFECT9999999995-26-000719
Mar 3, 2026S-8 POS0001193125-26-088213
Mar 3, 20268-K0001193125-26-086878
Mar 3, 2026S-8 POS0001193125-26-088221
Mar 3, 2026S-8 POS0001193125-26-088237
Mar 3, 2026S-8 POS0001193125-26-088261
Mar 3, 202625-NSE0001354457-26-000226
Mar 3, 2026S-8 POS0001193125-26-088206
Mar 3, 2026S-8 POS0001193125-26-088187
Mar 3, 2026S-8 POS0001193125-26-088248
Mar 3, 2026SC 14D9/A0001193125-26-086530
Mar 3, 2026SC TO-T/A0001193125-26-086527